Is ASPI or CC more profitable?

Chemours has a net margin of -6.82% compared to ASP Isotopes' net margin of -644.40%. Chemours' return on equity of 52.49% beat ASP Isotopes' return on equity. Company Net Margins Return on Equity Return on Assets ASP Isotopes -644.40% -112.46% -53.36% Chemours -6.82% 52.49% 1.78%

Which has stronger earnings and valuation, ASPI or AVNT?

Avient has higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than Avient, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ASP Isotopes $23.85M 36.05 -$175.09M -$2.08 N/A Avient $3.26B 0.97 $81.90M $1.72 20.04

Is ASPI or AVNT more profitable?

Avient has a net margin of 4.81% compared to ASP Isotopes' net margin of -644.40%. Avient's return on equity of 11.11% beat ASP Isotopes' return on equity. Company Net Margins Return on Equity Return on Assets ASP Isotopes -644.40% -112.46% -53.36% Avient 4.81% 11.11% 4.40%

Does the media refer more to ASPI or AVNT?

In the previous week, ASP Isotopes and ASP Isotopes both had 4 articles in the media. Avient's average media sentiment score of 1.08 beat ASP Isotopes' score of -0.70 indicating that Avient is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ASP Isotopes 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Avient 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings & valuation, ASPI or NGVT?

Ingevity has higher revenue and earnings than ASP Isotopes. Ingevity is trading at a lower price-to-earnings ratio than ASP Isotopes, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ASP Isotopes $23.85M 36.05 -$175.09M -$2.08 N/A Ingevity $1.17B 1.99 -$167.10M -$3.55 N/A

Is ASPI or NGVT more profitable?

Ingevity has a net margin of -10.55% compared to ASP Isotopes' net margin of -644.40%. Ingevity's return on equity of 207.82% beat ASP Isotopes' return on equity. Company Net Margins Return on Equity Return on Assets ASP Isotopes -644.40% -112.46% -53.36% Ingevity -10.55% 207.82% 9.70%

Does the media refer more to ASPI or NGVT?

In the previous week, ASP Isotopes had 2 more articles in the media than Ingevity. MarketBeat recorded 4 mentions for ASP Isotopes and 2 mentions for Ingevity. Ingevity's average media sentiment score of 0.06 beat ASP Isotopes' score of -0.70 indicating that Ingevity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ASP Isotopes 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Ingevity 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer ASPI or PCT?

In the previous week, ASP Isotopes and ASP Isotopes both had 4 articles in the media. PureCycle Technologies' average media sentiment score of 0.67 beat ASP Isotopes' score of -0.70 indicating that PureCycle Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ASP Isotopes 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative PureCycle Technologies 0 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is BAK or ASPI more profitable?

Braskem has a net margin of -13.72% compared to ASP Isotopes' net margin of -644.40%. Braskem's return on equity of -23.17% beat ASP Isotopes' return on equity. Company Net Margins Return on Equity Return on Assets Braskem -13.72% -23.17% 2.72% ASP Isotopes -644.40% -112.46% -53.36%

Does the media favor BAK or ASPI?

In the previous week, ASP Isotopes had 2 more articles in the media than Braskem. MarketBeat recorded 4 mentions for ASP Isotopes and 2 mentions for Braskem. Braskem's average media sentiment score of 0.50 beat ASP Isotopes' score of -0.70 indicating that Braskem is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Braskem 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ASP Isotopes 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative

ASP Isotopes (ASPI) Competitors

$6.83 +0.12 (+1.79%)

Closing price 06/8/2026 04:00 PM Eastern

Extended Trading

$6.94 +0.11 (+1.55%)

As of 07:49 AM Eastern

Compare

ASPI vs. CC, AVNT, NGVT, PCT, and BAK

Should you buy ASP Isotopes stock or one of its competitors? MarketBeat compares ASP Isotopes with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with ASP Isotopes include Chemours (CC), Avient (AVNT), Ingevity (NGVT), PureCycle Technologies (PCT), and Braskem (BAK). These companies are all part of the "chemicals" industry.

How does ASP Isotopes compare to Chemours?

ASP Isotopes (NASDAQ:ASPI) and Chemours (NYSE:CC) are both basic materials companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk.

In the previous week, ASP Isotopes had 4 more articles in the media than Chemours. MarketBeat recorded 4 mentions for ASP Isotopes and 0 mentions for Chemours. ASP Isotopes' average media sentiment score of -0.70 beat Chemours' score of -1.00 indicating that ASP Isotopes is being referred to more favorably in the media.

Company	Overall Sentiment
ASP Isotopes	Negative
Chemours	Negative

16.8% of ASP Isotopes shares are owned by institutional investors. Comparatively, 76.3% of Chemours shares are owned by institutional investors. 14.4% of ASP Isotopes shares are owned by insiders. Comparatively, 0.9% of Chemours shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

ASP Isotopes has a beta of 3.42, meaning that its stock price is 242% more volatile than the broader market. Comparatively, Chemours has a beta of 1.4, meaning that its stock price is 40% more volatile than the broader market.

ASP Isotopes presently has a consensus target price of $13.00, indicating a potential upside of 90.34%. Chemours has a consensus target price of $24.60, indicating a potential upside of 17.90%. Given ASP Isotopes' higher possible upside, equities research analysts plainly believe ASP Isotopes is more favorable than Chemours.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ASP Isotopes	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Chemours	1 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.42

ASP Isotopes has higher earnings, but lower revenue than Chemours. Chemours is trading at a lower price-to-earnings ratio than ASP Isotopes, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ASP Isotopes	$23.85M	36.05	-$175.09M	-$2.08	N/A
Chemours	$5.81B	0.54	-$386M	-$2.64	N/A

Chemours has a net margin of -6.82% compared to ASP Isotopes' net margin of -644.40%. Chemours' return on equity of 52.49% beat ASP Isotopes' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ASP Isotopes	-644.40%	-112.46%	-53.36%
Chemours	-6.82%	52.49%	1.78%

Summary

ASP Isotopes beats Chemours on 9 of the 16 factors compared between the two stocks.

How does ASP Isotopes compare to Avient?

ASP Isotopes (NASDAQ:ASPI) and Avient (NYSE:AVNT) are both basic materials companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, media sentiment and analyst recommendations.

In the previous week, ASP Isotopes and ASP Isotopes both had 4 articles in the media. Avient's average media sentiment score of 1.08 beat ASP Isotopes' score of -0.70 indicating that Avient is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ASP Isotopes	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative
Avient	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Avient has a net margin of 4.81% compared to ASP Isotopes' net margin of -644.40%. Avient's return on equity of 11.11% beat ASP Isotopes' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ASP Isotopes	-644.40%	-112.46%	-53.36%
Avient	4.81%	11.11%	4.40%

ASP Isotopes presently has a consensus target price of $13.00, indicating a potential upside of 90.34%. Avient has a consensus target price of $45.71, indicating a potential upside of 32.62%. Given ASP Isotopes' higher possible upside, analysts plainly believe ASP Isotopes is more favorable than Avient.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ASP Isotopes	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Avient	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43

16.8% of ASP Isotopes shares are owned by institutional investors. Comparatively, 95.5% of Avient shares are owned by institutional investors. 14.4% of ASP Isotopes shares are owned by insiders. Comparatively, 0.9% of Avient shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

ASP Isotopes has a beta of 3.42, indicating that its share price is 242% more volatile than the broader market. Comparatively, Avient has a beta of 1.28, indicating that its share price is 28% more volatile than the broader market.

Avient has higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than Avient, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ASP Isotopes	$23.85M	36.05	-$175.09M	-$2.08	N/A
Avient	$3.26B	0.97	$81.90M	$1.72	20.04

Summary

Avient beats ASP Isotopes on 11 of the 15 factors compared between the two stocks.

How does ASP Isotopes compare to Ingevity?

ASP Isotopes (NASDAQ:ASPI) and Ingevity (NYSE:NGVT) are both basic materials companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, media sentiment, profitability, risk, earnings, analyst recommendations, dividends and valuation.

Ingevity has higher revenue and earnings than ASP Isotopes. Ingevity is trading at a lower price-to-earnings ratio than ASP Isotopes, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ASP Isotopes	$23.85M	36.05	-$175.09M	-$2.08	N/A
Ingevity	$1.17B	1.99	-$167.10M	-$3.55	N/A

ASP Isotopes has a beta of 3.42, meaning that its stock price is 242% more volatile than the broader market. Comparatively, Ingevity has a beta of 1.18, meaning that its stock price is 18% more volatile than the broader market.

ASP Isotopes presently has a consensus target price of $13.00, indicating a potential upside of 90.34%. Ingevity has a consensus target price of $80.00, indicating a potential upside of 19.53%. Given ASP Isotopes' stronger consensus rating and higher probable upside, equities research analysts clearly believe ASP Isotopes is more favorable than Ingevity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ASP Isotopes	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Ingevity	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

16.8% of ASP Isotopes shares are owned by institutional investors. Comparatively, 91.6% of Ingevity shares are owned by institutional investors. 14.4% of ASP Isotopes shares are owned by company insiders. Comparatively, 0.9% of Ingevity shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, ASP Isotopes had 2 more articles in the media than Ingevity. MarketBeat recorded 4 mentions for ASP Isotopes and 2 mentions for Ingevity. Ingevity's average media sentiment score of 0.06 beat ASP Isotopes' score of -0.70 indicating that Ingevity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ASP Isotopes	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative
Ingevity	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Ingevity has a net margin of -10.55% compared to ASP Isotopes' net margin of -644.40%. Ingevity's return on equity of 207.82% beat ASP Isotopes' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ASP Isotopes	-644.40%	-112.46%	-53.36%
Ingevity	-10.55%	207.82%	9.70%

Summary

ASP Isotopes beats Ingevity on 8 of the 15 factors compared between the two stocks.

How does ASP Isotopes compare to PureCycle Technologies?

ASP Isotopes (NASDAQ:ASPI) and PureCycle Technologies (NASDAQ:PCT) are both chemicals companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, risk, analyst recommendations, valuation, institutional ownership, profitability, earnings and dividends.

ASP Isotopes presently has a consensus price target of $13.00, suggesting a potential upside of 90.34%. PureCycle Technologies has a consensus price target of $12.00, suggesting a potential downside of 0.17%. Given ASP Isotopes' higher probable upside, analysts plainly believe ASP Isotopes is more favorable than PureCycle Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ASP Isotopes	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
PureCycle Technologies	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

In the previous week, ASP Isotopes and ASP Isotopes both had 4 articles in the media. PureCycle Technologies' average media sentiment score of 0.67 beat ASP Isotopes' score of -0.70 indicating that PureCycle Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ASP Isotopes	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative
PureCycle Technologies	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

ASP Isotopes has higher revenue and earnings than PureCycle Technologies. PureCycle Technologies is trading at a lower price-to-earnings ratio than ASP Isotopes, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ASP Isotopes	$23.85M	36.05	-$175.09M	-$2.08	N/A
PureCycle Technologies	$8.35M	260.35	-$182.57M	-$1.47	N/A

ASP Isotopes has a net margin of -644.40% compared to PureCycle Technologies' net margin of -2,062.36%. ASP Isotopes' return on equity of -112.46% beat PureCycle Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ASP Isotopes	-644.40%	-112.46%	-53.36%
PureCycle Technologies	-2,062.36%	-393.01%	-22.56%

ASP Isotopes has a beta of 3.42, meaning that its share price is 242% more volatile than the broader market. Comparatively, PureCycle Technologies has a beta of 2.48, meaning that its share price is 148% more volatile than the broader market.

16.8% of ASP Isotopes shares are held by institutional investors. Comparatively, 63.0% of PureCycle Technologies shares are held by institutional investors. 14.4% of ASP Isotopes shares are held by insiders. Comparatively, 18.8% of PureCycle Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

ASP Isotopes and PureCycle Technologies tied by winning 8 of the 16 factors compared between the two stocks.

How does ASP Isotopes compare to Braskem?

Braskem (NYSE:BAK) and ASP Isotopes (NASDAQ:ASPI) are both small-cap chemicals companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, media sentiment, institutional ownership and dividends.

16.8% of ASP Isotopes shares are owned by institutional investors. 0.0% of Braskem shares are owned by company insiders. Comparatively, 14.4% of ASP Isotopes shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

ASP Isotopes has lower revenue, but higher earnings than Braskem. ASP Isotopes is trading at a lower price-to-earnings ratio than Braskem, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Braskem	$12.66B	0.11	-$1.77B	-$4.22	N/A
ASP Isotopes	$23.85M	36.05	-$175.09M	-$2.08	N/A

In the previous week, ASP Isotopes had 2 more articles in the media than Braskem. MarketBeat recorded 4 mentions for ASP Isotopes and 2 mentions for Braskem. Braskem's average media sentiment score of 0.50 beat ASP Isotopes' score of -0.70 indicating that Braskem is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Braskem	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ASP Isotopes	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

Braskem has a net margin of -13.72% compared to ASP Isotopes' net margin of -644.40%. Braskem's return on equity of -23.17% beat ASP Isotopes' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Braskem	-13.72%	-23.17%	2.72%
ASP Isotopes	-644.40%	-112.46%	-53.36%

Braskem presently has a consensus price target of $3.40, suggesting a potential downside of 3.55%. ASP Isotopes has a consensus price target of $13.00, suggesting a potential upside of 90.34%. Given ASP Isotopes' stronger consensus rating and higher probable upside, analysts plainly believe ASP Isotopes is more favorable than Braskem.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Braskem	4 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.63
ASP Isotopes	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Braskem has a beta of 1.57, meaning that its stock price is 57% more volatile than the broader market. Comparatively, ASP Isotopes has a beta of 3.42, meaning that its stock price is 242% more volatile than the broader market.

Summary

ASP Isotopes beats Braskem on 10 of the 16 factors compared between the two stocks.

Get ASP Isotopes News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ASPI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ASPI vs. The Competition

Export

Metric	ASP Isotopes	CHEM Industry	Materials Sector	NASDAQ Exchange
Market Cap	$844.81M	$13.07B	$4.68B	$11.99B
Dividend Yield	N/A	2.25%	4.99%	5.58%
P/E Ratio	-3.28	35.45	22.15	23.74
Price / Sales	36.05	2.04	6,510.17	110.46
Price / Cash	N/A	12.13	24.18	37.25
Price / Book	2.88	1.93	8.99	6.78
Net Income	-$175.09M	$162.94M	$156.92M	$337.51M
7 Day Performance	-18.01%	-4.53%	-5.20%	-2.34%
1 Month Performance	26.95%	0.45%	-5.36%	1.88%
1 Year Performance	-29.00%	31.20%	57.18%	25.55%

ASP Isotopes Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ASPI ASP Isotopes	2.0615 of 5 stars	$6.83 +1.8%	$13.00 +90.3%	-27.0%	$844.81M	$23.85M	N/A	76	Gap Up
CC Chemours	3.1987 of 5 stars	$22.40 +1.1%	$24.60 +9.8%	+88.0%	$3.33B	$5.82B	N/A	5,700
AVNT Avient	4.7404 of 5 stars	$34.63 -2.2%	$46.40 +34.0%	-6.9%	$3.25B	$3.26B	20.13	9,000	Positive News Analyst Forecast
NGVT Ingevity	3.1262 of 5 stars	$66.41 -2.1%	$80.00 +20.5%	+59.4%	$2.36B	$1.18B	N/A	1,500	Negative News
PCT PureCycle Technologies	1.3437 of 5 stars	$12.23 -1.3%	$12.00 -1.9%	+21.7%	$2.24B	$8.35M	N/A	120

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ASPI) was last updated on 6/9/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ASP Isotopes (ASPI) Competitors

ASPI vs. CC, AVNT, NGVT, PCT, and BAK

How does ASP Isotopes compare to Chemours?

Summary

How does ASP Isotopes compare to Avient?

Summary

How does ASP Isotopes compare to Ingevity?

Summary

How does ASP Isotopes compare to PureCycle Technologies?

Summary

How does ASP Isotopes compare to Braskem?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ASPI vs. The Competition

ASP Isotopes Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ASP Isotopes (ASPI) Competitors

ASPI vs. CC, AVNT, NGVT, PCT, and BAK

How does ASP Isotopes compare to Chemours?

Does the media refer more to ASPI or CC?

Do insiders & institutionals believe in ASPI or CC?

Which has more volatility and risk, ASPI or CC?

Do analysts rate ASPI or CC?

Which has stronger earnings & valuation, ASPI or CC?

Is ASPI or CC more profitable?

Summary

How does ASP Isotopes compare to Avient?

Does the media refer more to ASPI or AVNT?

Is ASPI or AVNT more profitable?

Do analysts prefer ASPI or AVNT?

Do insiders and institutionals believe in ASPI or AVNT?

Which has more risk and volatility, ASPI or AVNT?

Which has stronger earnings and valuation, ASPI or AVNT?

Summary

How does ASP Isotopes compare to Ingevity?

Which has preferable earnings & valuation, ASPI or NGVT?

Which has more risk and volatility, ASPI or NGVT?

Do analysts recommend ASPI or NGVT?

Do institutionals and insiders believe in ASPI or NGVT?

Does the media refer more to ASPI or NGVT?

Is ASPI or NGVT more profitable?

Summary

How does ASP Isotopes compare to PureCycle Technologies?

Do analysts prefer ASPI or PCT?

Does the media prefer ASPI or PCT?

Which has higher valuation & earnings, ASPI or PCT?

Is ASPI or PCT more profitable?

Which has more risk and volatility, ASPI or PCT?

Do institutionals and insiders hold more shares of ASPI or PCT?

Summary

How does ASP Isotopes compare to Braskem?

Do institutionals & insiders hold more shares of BAK or ASPI?

Which has better earnings and valuation, BAK or ASPI?

Does the media favor BAK or ASPI?

Is BAK or ASPI more profitable?

Do analysts rate BAK or ASPI?

Which has more risk and volatility, BAK or ASPI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ASPI vs. The Competition

ASP Isotopes Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools